PTC Therapeutics Reports Third Quarter 2017 Financial Results and Provides Corporate Update

Go back to PTC Therapeutics Reports Third Quarter 2017 Financial Results and Provides Corporate Update
PTC THERAPEUTICS (NASDAQ: PTCT) Delayed: 80.92 +1.94 (2.46%)
Previous Close $78.98    52 Week High $35.40 
Open $80.00    52 Week Low $4.03 
Day High $81.71    P/E 8.61 
Day Low $79.51    EPS $9.40 
Volume 1,609,646